ID

21504

Beschrijving

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00416312

Link

https://clinicaltrials.gov/show/NCT00416312

Trefwoorden

Versies (1)
  1. 25-04-17 25-04-17 -
Geüploaded op

25 april 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Lymphoma NCT00416312

Engels

Eligibility Lymphoma NCT00416312

1 Formulieren  
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00416312
Criteria
Beschrijving

Criteria

diagnosis of non-hodgkin's lymphoma
Beschrijving

Lymphoma, Non-Hodgkin

Datatype

boolean

Alias
UMLS CUI [1]
C0024305
measurable disease by ct scan or nuclear medicine imaging
Beschrijving

Measurable Disease X-Ray Computed Tomography | Measurable Disease Radionuclide Imaging

Datatype

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0040405
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C0034606
eligible, by standard of care criteria, for iodine i 131 tositumomab or yttrium y 90 ibritumomab tiuxetan treatment
Beschrijving

Standard of Care criteria | Iodine-131 [I-131] tositumomab | yttrium-90-ibritumomab tiuxetan

Datatype

boolean

Alias
UMLS CUI [1,1]
C2936643
UMLS CUI [1,2]
C0243161
UMLS CUI [2]
C1260363
UMLS CUI [3]
C1134535
patient characteristics:
Beschrijving

Client Characteristics

Datatype

boolean

Alias
UMLS CUI [1]
C0815172
no other malignancy within the past 3 years except basal cell carcinoma or squamous cell carcinoma of the skin or in situ carcinoma of the cervix
Beschrijving

Malignant Neoplasms Absent | Basal cell carcinoma | Squamous cell carcinoma of skin | Carcinoma in situ of uterine cervix

Datatype

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0332197
UMLS CUI [2]
C0007117
UMLS CUI [3]
C0553723
UMLS CUI [4]
C0851140
not pregnant or nursing
Beschrijving

Pregnancy Absent | Breast Feeding Absent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C0332197
fertile patients must use effective contraception
Beschrijving

Fertility Contraceptive methods

Datatype

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
no alcoholism or drug abuse within the past 2 years
Beschrijving

Chronic Alcoholic Intoxication Absent | Drug abuse Absent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0001973
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0013146
UMLS CUI [2,2]
C0332197
no severe emotional, behavioral, or psychiatric problems that would limit study compliance
Beschrijving

Emotional problems Severe Absent | Behaviorial problem Severe Absent | Psychiatric problem Severe Absent | Mental problem Protocol Compliance Limited

Datatype

boolean

Alias
UMLS CUI [1,1]
C0677660
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C0233514
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C0332197
UMLS CUI [3,1]
C1306597
UMLS CUI [3,2]
C0205082
UMLS CUI [3,3]
C0332197
UMLS CUI [4,1]
C0848067
UMLS CUI [4,2]
C0525058
UMLS CUI [4,3]
C0439801
prior concurrent therapy:
Beschrijving

Therapeutic procedure

Datatype

boolean

Alias
UMLS CUI [1]
C0087111
no concurrent participation in another investigational drug study
Beschrijving

Study Subject Participation Status Exclusion | Investigational New Drugs Absent

Datatype

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C2828389
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C0332197
Terug naar het begin van de pagina

Similar models

Eligibility Lymphoma NCT00416312

1 Formulieren
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00416312
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Lymphoma, Non-Hodgkin
Item
diagnosis of non-hodgkin's lymphoma
boolean
C0024305 (UMLS CUI [1])
Measurable Disease X-Ray Computed Tomography | Measurable Disease Radionuclide Imaging
Item
measurable disease by ct scan or nuclear medicine imaging
boolean
C1513041 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2,1])
C0034606 (UMLS CUI [2,2])
Standard of Care criteria | Iodine-131 [I-131] tositumomab | yttrium-90-ibritumomab tiuxetan
Item
eligible, by standard of care criteria, for iodine i 131 tositumomab or yttrium y 90 ibritumomab tiuxetan treatment
boolean
C2936643 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C1260363 (UMLS CUI [2])
C1134535 (UMLS CUI [3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Malignant Neoplasms Absent | Basal cell carcinoma | Squamous cell carcinoma of skin | Carcinoma in situ of uterine cervix
Item
no other malignancy within the past 3 years except basal cell carcinoma or squamous cell carcinoma of the skin or in situ carcinoma of the cervix
boolean
C0006826 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0007117 (UMLS CUI [2])
C0553723 (UMLS CUI [3])
C0851140 (UMLS CUI [4])
Pregnancy Absent | Breast Feeding Absent
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Chronic Alcoholic Intoxication Absent | Drug abuse Absent
Item
no alcoholism or drug abuse within the past 2 years
boolean
C0001973 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0013146 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Emotional problems Severe Absent | Behaviorial problem Severe Absent | Psychiatric problem Severe Absent | Mental problem Protocol Compliance Limited
Item
no severe emotional, behavioral, or psychiatric problems that would limit study compliance
boolean
C0677660 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0233514 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C1306597 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C0848067 (UMLS CUI [4,1])
C0525058 (UMLS CUI [4,2])
C0439801 (UMLS CUI [4,3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Study Subject Participation Status Exclusion | Investigational New Drugs Absent
Item
no concurrent participation in another investigational drug study
boolean
C2348568 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial